Harvard Bioscience Announces Filing of IPO Registration Statement for Harvard Apparatus Regenerative Technology Wednesday, December 12, 4:51 PM ET
Harvard Bioscience (NASDAQ:HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, announced that its wholly-owned subsidiary, Harvard Apparatus Regenerative Technology, Inc., filed a registration statement with the SEC for an initial public offering, or IPO, of Harvard Apparatus Regenerative Technology's common stock. Following the IPO, Harvard Apparatus Regenerative Technology will own Harvard Bioscience's regenerative medicine device business, which develops life-saving medical devices in the field of regenerative medicine, including devices to be used by physicians for growing organs outside the body for transplant.
Following the IPO, Harvard Bioscience will own at least 80% of Harvard Apparatus Regenerative Technology's common stock. Harvard Bioscience intends to distribute its remaining interest in Harvard Apparatus Regenerative Technology to Harvard Bioscience's shareholders in a pro-rata, tax-free dividend approximately 120 days following the closing of the IPO.
Summer Street Research Partners will act as sole book-running manager for the offering.
Orchestra BioMed Holdings is Now Oversold (OBIO) Friday, April 26, 4:33 PM ET, by Market News Video Staff Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
Noah Holdings (NOAH) Shares Cross Above 200 DMA Friday, April 26, 4:10 PM ET, by Market News Video Staff In trading on Friday, shares of Noah Holdings Ltd (NOAH) crossed above their 200 day ...
Shares of SHM Now Oversold Friday, April 26, 4:10 PM ET, by Market News Video Staff In trading on Friday, shares of the SPDR Nuveen Bloomberg Short Term Municipal Bond ETF ...
PAG Crosses Above Key Moving Average Level Friday, April 26, 4:09 PM ET, by Market News Video Staff In trading on Friday, shares of Penske Automotive Group Inc (PAG) crossed above their 200 ...
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.